These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
857 related items for PubMed ID: 12481428
1. X-linked inhibitor of apoptosis (XIAP) blocks Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand-mediated apoptosis of prostate cancer cells in the presence of mitochondrial activation: sensitization by overexpression of second mitochondria-derived activator of caspase/direct IAP-binding protein with low pl (Smac/DIABLO). Ng CP, Bonavida B. Mol Cancer Ther; 2002 Oct; 1(12):1051-8. PubMed ID: 12481428 [Abstract] [Full Text] [Related]
2. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance. Ng CP, Zisman A, Bonavida B. Prostate; 2002 Dec 01; 53(4):286-99. PubMed ID: 12430140 [Abstract] [Full Text] [Related]
3. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis of human melanoma is regulated by smac/DIABLO release from mitochondria. Zhang XD, Zhang XY, Gray CP, Nguyen T, Hersey P. Cancer Res; 2001 Oct 01; 61(19):7339-48. PubMed ID: 11585775 [Abstract] [Full Text] [Related]
4. Ectopic overexpression of second mitochondria-derived activator of caspases (Smac/DIABLO) or cotreatment with N-terminus of Smac/DIABLO peptide potentiates epothilone B derivative-(BMS 247550) and Apo-2L/TRAIL-induced apoptosis. Guo F, Nimmanapalli R, Paranawithana S, Wittman S, Griffin D, Bali P, O'Bryan E, Fumero C, Wang HG, Bhalla K. Blood; 2002 May 01; 99(9):3419-26. PubMed ID: 11964312 [Abstract] [Full Text] [Related]
5. Molecular determinants of the caspase-promoting activity of Smac/DIABLO and its role in the death receptor pathway. Srinivasula SM, Datta P, Fan XJ, Fernandes-Alnemri T, Huang Z, Alnemri ES. J Biol Chem; 2000 Nov 17; 275(46):36152-7. PubMed ID: 10950947 [Abstract] [Full Text] [Related]
6. Activation of ERK1/2 protects melanoma cells from TRAIL-induced apoptosis by inhibiting Smac/DIABLO release from mitochondria. Zhang XD, Borrow JM, Zhang XY, Nguyen T, Hersey P. Oncogene; 2003 May 15; 22(19):2869-81. PubMed ID: 12771938 [Abstract] [Full Text] [Related]
7. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells. Roa WH, Chen H, Fulton D, Gulavita S, Shaw A, Th'ng J, Farr-Jones M, Moore R, Petruk K. Clin Invest Med; 2003 Oct 15; 26(5):231-42. PubMed ID: 14596484 [Abstract] [Full Text] [Related]
8. Involvement of proapoptotic molecules Bax and Bak in tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced mitochondrial disruption and apoptosis: differential regulation of cytochrome c and Smac/DIABLO release. Kandasamy K, Srinivasula SM, Alnemri ES, Thompson CB, Korsmeyer SJ, Bryant JL, Srivastava RK. Cancer Res; 2003 Apr 01; 63(7):1712-21. PubMed ID: 12670926 [Abstract] [Full Text] [Related]
9. Proteasome-mediated degradation of Smac during apoptosis: XIAP promotes Smac ubiquitination in vitro. MacFarlane M, Merrison W, Bratton SB, Cohen GM. J Biol Chem; 2002 Sep 27; 277(39):36611-6. PubMed ID: 12121969 [Abstract] [Full Text] [Related]
10. Potent antileukemic interactions between flavopiridol and TRAIL/Apo2L involve flavopiridol-mediated XIAP downregulation. Rosato RR, Dai Y, Almenara JA, Maggio SC, Grant S. Leukemia; 2004 Nov 27; 18(11):1780-8. PubMed ID: 15385934 [Abstract] [Full Text] [Related]
11. TRAIL-induced apoptosis requires Bax-dependent mitochondrial release of Smac/DIABLO. Deng Y, Lin Y, Wu X. Genes Dev; 2002 Jan 01; 16(1):33-45. PubMed ID: 11782443 [Abstract] [Full Text] [Related]
12. A small molecule Smac-mimic compound induces apoptosis and sensitizes TRAIL- and etoposide-induced apoptosis in breast cancer cells. Bockbrader KM, Tan M, Sun Y. Oncogene; 2005 Nov 10; 24(49):7381-8. PubMed ID: 16044155 [Abstract] [Full Text] [Related]
13. Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo. Fulda S, Wick W, Weller M, Debatin KM. Nat Med; 2002 Aug 10; 8(8):808-15. PubMed ID: 12118245 [Abstract] [Full Text] [Related]
14. Tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis is inhibited by Bcl-2 but restored by the small molecule Bcl-2 inhibitor, HA 14-1, in human colon cancer cells. Sinicrope FA, Penington RC, Tang XM. Clin Cancer Res; 2004 Dec 15; 10(24):8284-92. PubMed ID: 15623604 [Abstract] [Full Text] [Related]
15. Actinomycin D and gemcitabine synergistically sensitize androgen-independent prostate cancer cells to Apo2L/TRAIL-mediated apoptosis. Zisman A, Ng CP, Pantuck AJ, Bonavida B, Belldegrun AS. J Immunother; 2001 Dec 15; 24(6):459-71. PubMed ID: 11759069 [Abstract] [Full Text] [Related]
16. A Smac-mimetic sensitizes prostate cancer cells to TRAIL-induced apoptosis via modulating both IAPs and NF-kappaB. Dai Y, Liu M, Tang W, Li Y, Lian J, Lawrence TS, Xu L. BMC Cancer; 2009 Nov 06; 9():392. PubMed ID: 19895686 [Abstract] [Full Text] [Related]
17. Adriamycin sensitizes the adriamycin-resistant 8226/Dox40 human multiple myeloma cells to Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-mediated (TRAIL) apoptosis. Jazirehi AR, Ng CP, Gan XH, Schiller G, Bonavida B. Clin Cancer Res; 2001 Dec 06; 7(12):3874-83. PubMed ID: 11751478 [Abstract] [Full Text] [Related]
18. Reactive oxygen species regulate caspase activation in tumor necrosis factor-related apoptosis-inducing ligand-resistant human colon carcinoma cell lines. Izeradjene K, Douglas L, Tillman DM, Delaney AB, Houghton JA. Cancer Res; 2005 Aug 15; 65(16):7436-45. PubMed ID: 16103097 [Abstract] [Full Text] [Related]
19. Regulation of Apo2L/tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in thyroid carcinoma cells. Poulaki V, Mitsiades CS, Kotoula V, Tseleni-Balafouta S, Ashkenazi A, Koutras DA, Mitsiades N. Am J Pathol; 2002 Aug 15; 161(2):643-54. PubMed ID: 12163389 [Abstract] [Full Text] [Related]
20. Smac3, a novel Smac/DIABLO splicing variant, attenuates the stability and apoptosis-inhibiting activity of X-linked inhibitor of apoptosis protein. Fu J, Jin Y, Arend LJ. J Biol Chem; 2003 Dec 26; 278(52):52660-72. PubMed ID: 14523016 [Abstract] [Full Text] [Related] Page: [Next] [New Search]